Exactly. The only one hurting ERHC is Peter Ntephe when he didn't disclose the IRS fiasco for over a year and caused a lien to be placed on ERHC assets. He also issued millions in convertible debt causing billions of shares of dilution. He also has refused to discuss financing plans going forward and, with a going concern statement in effect, this makes investors question if this company can survive past this one well.
These are the only things hurting the ERHC share price and these are the only things hurting us shareholders. You can be certain if these issues were discussed and resolved the share price would be far higher. They have not been discussed and they have not been resolved so the share price languishes. No real surprise. With these questions unanswered the risk outweighs the reward.
Blaming the current share price on anything other than the root cause of inadequate disclosure of vital facts is ludicrous and every real investor knows it.
News 
Market Data 
Discover 
AI
